000 01523 a2200433 4500
005 20250514053552.0
264 0 _c20030110
008 200301s 0 0 eng d
022 _a1055-3207
024 7 _a10.1016/s1055-3207(02)00025-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDonahue, James M
245 0 0 _aViral oncolysis.
_h[electronic resource]
260 _bSurgical oncology clinics of North America
_cJul 2002
300 _a661-80 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAnimals
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aNewcastle disease virus
_xgenetics
650 0 4 _aOncogenic Viruses
_xgenetics
650 0 4 _aReoviridae
_xgenetics
650 0 4 _aSimplexvirus
_xgenetics
650 0 4 _aVaccinia virus
_xgenetics
650 0 4 _aViral Proteins
_xgenetics
650 0 4 _aVirus Replication
_xgenetics
700 1 _aMullen, John T
700 1 _aTanabe, Kenneth K
773 0 _tSurgical oncology clinics of North America
_gvol. 11
_gno. 3
_gp. 661-80
856 4 0 _uhttps://doi.org/10.1016/s1055-3207(02)00025-x
_zAvailable from publisher's website
999 _c12291349
_d12291349